UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 19, 2011 (August 15, 2011)
UNILIFE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware | 001-34540 | 27-1049354 | ||
(State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
250 Cross Farm Lane, York,
Pennsylvania |
17406 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (717) 384-3400
Not
Applicable |
(Former name or former address if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement
On August 15, 2011, Unilife Medical Solutions, Inc. (“UMSI”), a subsidiary of Unilife Corporation (the “Company”) entered into a Master Lease Agreement dated as of August 15, 2011 (the “Master Agreement”) with Varilease Finance, Inc. (“Varilease”). Under the Master Agreement, Varilease agreed to provide lease financing in an amount of $10 million for the production equipment for the Unifill® ready-to-fill syringe (the “Equipment”). UMSI may apply funds it receives from Varilease under the Master Agreement as reimbursement for payments UMSI has previously made to the manufacturer of the Equipment.
Under the terms of the Master Agreement, UMSI will lease the Equipment from Varilease for a two-year base term, and UMSI will pay rent in 24 equal monthly installments over the base term. The monthly rent payments include a Base Lease Rate Factor of 0.04195, which is subject to increase 0.00006775 for every five (5) basis point increase in 24-month U.S. Treasury Notes, until all the Equipment has been installed. The 24-month U.S. Treasury Note yield used as the basis for the derivation of the Base Lease Rate Factor is .33%. UMSI will pay a deposit equal to two months rent, which will be applied towards the last two months rental payments.
The Master Agreement contains covenants and provisions for events of default customarily found in lease agreements.
In connection with the Master
Agreement, the Company executed a Guaranty dated as of August 15, 2011
(the “Guaranty”) in favor of Varilease pursuant to which the
Company unconditionally guaranteed UMSI’s performance under the Master
Agreement, including payment of all rent payments or other amounts owed by UMSI
under the Master Agreement. The Guaranty is unsecured, and the Company is not
required to pledge any of its assets as security for its obligations under the
Guaranty.
All capitalized terms that are not otherwise defined
herein have the meanings ascribed to them in the Master Agreement.
The foregoing contains
forward-looking statements, which are based on management’s beliefs and
assumptions and on information currently available to our management. The
Company’s management believes that these forward-looking statements are
reasonable as and when made. The Company does not undertake any obligation to
publicly update or revise any forward-looking statements, whether as a result
of new information, future events or otherwise, except as required by law. In
addition, forward-looking statements are subject to certain risks and
uncertainties that could cause actual results, events and developments to
differ materially from the Company’s historical experience and its
present expectations or projections. These risks and uncertainties include, but
are not limited to, those described in “Item 1A. Risk Factors” in
the Company’s registration statement on Form 10-K and those described
from time to time in other reports which the Company files with the Securities
and Exchange Commission.
Item 2.03 Creation of a
Direct Financial Obligation or an Obligation under an Off-Balance Sheet
Arrangement of a Registrant
Reference is hereby made to Item 1.01 which is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
Unilife Corporation | ||||
Date: August 19, 2011
|
By: | /s/ Alan Shortall | ||
|
||||
|
Alan Shortall Chief Executive Officer |